AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

ESCITALOPRAM 20 Mg ;

10 registrations across 1 African market— 10 active

Markets with ESCITALOPRAM 20 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Joviapram 20 mg
Film Coated Tablets
🇪🇬EgyptSun pharma Egypt limitedactive
Joviapram 20 mg
Film Coated Tablets
🇪🇬EgyptSun pharma Egypt limitedactive
Citapronex 20 mg
Film Coated Tablets
🇪🇬EgyptChemipharm Pharmaceutical Industriesactive
Citalomep 20 mg
Film Coated Tablets
🇪🇬EgyptArab Company for Pharmaceuticals and Medicinal Plants _ Mepaco- Medi Foodactive
Moodamash 20 mg
Film Coated Tablets
🇪🇬EgyptMash tech for pharmaceutical industries - local under constructionactive
Moodamash 20 mg
Film Coated Tablets
🇪🇬EgyptMash tech for pharmaceutical industries - local under constructionactive
Elarpic
Film Coated Tablets
🇪🇬EgyptElixir pharmaactive
Citapronex 20 mg
Film Coated Tablets
🇪🇬EgyptChemipharm Pharmaceutical Industriesactive
Citalomep 20 mg
Film Coated Tablets
🇪🇬EgyptArab Company for Pharmaceuticals and Medicinal Plants _ Mepaco- Medi Foodactive
Elarpic
Film Coated Tablets
🇪🇬EgyptElixir pharmaactive

ESCITALOPRAM 20 Mg ; in Africa — Regulatory Overview

ESCITALOPRAM 20 Mg ; is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 10 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.